| Hans-Günter Meyer-Thompson | Amphetamine
Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada.
Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada.
Morin KA, Vojtesek F, Acharya S, Marsh DC.
Front Psychiatry. 2021 Dec 20;12:782066. doi: 10.3389/fpsyt.2021.782066. PMID: 34987430; PMCID: PMC8721960.